Supplementary Figure S3 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
Key Points
Key points are not available for this paper at this time.
Abstract
SCLC-specific markers are weak/lost in SMARCA4-deficient SCLC-Y cell lines.
Supplementary Figure S3 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies | Synapse